Skip to content
Recall Observatory FDA recall evidence

Drug product

Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

D-1384-2012

April 23, 2012

Class III

Product summary

Firm
Teva Pharmaceuticals USA, Inc.
Event
Event 61759
Status
Terminated
Classification
Class III
Quantity
40,750 Dispensers
Official record key
drug-enforcement:D-1384-2012

Official wording

Reason: Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

Code information: Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

Field note

Send feedback

We'll only use this to respond to your feedback.